Join Us

Positive News & Developments When Treating Chronic Lymphocytic Leukaemia From The EHA

Professors Simon Rule, Peter Hillmen and John Gribben are leading UK clinical researchers with a special interest in CLL. In this brief news report from this year's EHA meeting in Milan they share insights into the promising future for CLL treatment as greater understanding of the biology of this complex disease brings with it an increasing range of potential therapies.

This page was last reviewed 22nd October 2019. Next review October 2022

Send us feedback about this page